Published in Clin Exp Immunol on April 01, 1974
Pathogenicity of influenza virus. Microbiol Rev (1980) 2.80
Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages. Infect Immun (1982) 1.19
Influenza viruses and staphylococci in vitro: some interactions with polymorphonuclear leucocytes and epithelial cells. Br J Exp Pathol (1977) 0.94
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
Thermal stability and interaction with ferret inflammatory exudates of two clones of influenza virus of differing virulence for both ferrets and man. Br J Exp Pathol (1977) 0.90
Interaction of influenza A virus with human peripheral blood lymphocytes. Infect Immun (1979) 0.88
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate. J Cell Biol (1968) 11.00
Attachment and penetration of influenza virus. Virology (1962) 2.42
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Ultrastructural localization of acid phosphatase in human buccal epithelium. Arch Oral Biol (1970) 0.96
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Coronaviridae: second report. Intervirology (1978) 2.05
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39
Live influenza vaccines. Lancet (1983) 1.39
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Picornaviridae. Intervirology (1974) 1.36
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet (1981) 1.27
Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother (1987) 1.27
Titration of tuberculin, nucleic acids and viruses by haemaggregation inhibition using a "pattern" test. Br J Exp Pathol (1967) 1.26
An epidemic of influenza on Tristan da Cunha. J Hyg (Lond) (1973) 1.26
Identification of rhinovirus stran D.C. Nature (1968) 1.24
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
Skin tests with influenza virus. J Hyg (Lond) (1973) 1.22
Viruses in febrile convulsions. Lancet (1980) 1.22
Possible virus in schizophrenia and some neurological disorders. Lancet (1979) 1.21
Purified interferon as protection against rhinovirus infection. Br Med J (Clin Res Ed) (1982) 1.21
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol (2001) 1.19
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child (1978) 1.18
Drug resistant rhinoviruses from the nose of experimentally treated volunteers. Arch Virol (1989) 1.18
Interferon: therapeutic fact or fiction for the '80s? Br Med J (1980) 1.18
Arthritis after meningococcal meningitis. Br Med J (1977) 1.16
A cytotoxic factor in cholera toxin. Br J Exp Pathol (1970) 1.16
Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med (1986) 1.16
Studies on the antiviral activity of 1-adamantanamine. Br J Exp Pathol (1965) 1.16
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Some inhibitors of the effect of cholera toxin on HeLa cells. Exp Mol Pathol (1973) 1.12